327 related articles for article (PubMed ID: 20354203)
1. Alterations in glycosylation as biomarkers for cancer detection.
Reis CA; Osorio H; Silva L; Gomes C; David L
J Clin Pathol; 2010 Apr; 63(4):322-9. PubMed ID: 20354203
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of altered glycosylation of glycoproteins in cancer.
Orntoft TF; Vestergaard EM
Electrophoresis; 1999 Feb; 20(2):362-71. PubMed ID: 10197444
[TBL] [Abstract][Full Text] [Related]
3. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
4. CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):981-6. PubMed ID: 12923370
[TBL] [Abstract][Full Text] [Related]
5. Precancerous lesions and biologic markers in esophageal cancer.
Mufti SI; Zirvi KA; Garewal HS
Cancer Detect Prev; 1991; 15(4):291-301. PubMed ID: 1794136
[TBL] [Abstract][Full Text] [Related]
6. Identification of neoplastic cells in the lymphocytic infiltrate associated with thin melanomas.
Salvio AG; Ribeiro DA; Marques ME
Histopathology; 2007 Jun; 50(7):942-4. PubMed ID: 17543085
[No Abstract] [Full Text] [Related]
7. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Satomaa T; Heiskanen A; Leonardsson I; Angström J; Olonen A; Blomqvist M; Salovuori N; Haglund C; Teneberg S; Natunen J; Carpén O; Saarinen J
Cancer Res; 2009 Jul; 69(14):5811-9. PubMed ID: 19584298
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
9. Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Berriel E; Hill M; Barcia JJ; Ubillos L; Gonzalez M; Detjen G; Rondan M; Navarrete H; Osinaga E
Oncol Rep; 2005 Jul; 14(1):219-27. PubMed ID: 15944793
[TBL] [Abstract][Full Text] [Related]
10. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
Zhao J; Qiu W; Simeone DM; Lubman DM
J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
[TBL] [Abstract][Full Text] [Related]
11. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
[TBL] [Abstract][Full Text] [Related]
15. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
16. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
Kumar SR; Sauter ER; Quinn TP; Deutscher SL
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
[TBL] [Abstract][Full Text] [Related]
17. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
18. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives.
Hakomori S
Cancer Res; 1985 Jun; 45(6):2405-14. PubMed ID: 3886132
[No Abstract] [Full Text] [Related]
19. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
20. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
